Who Wants to Switch? Gauging Patient Interest in Novel Antiretroviral Therapies | Zendy

Caroline Derrick | Zendy; Jan Ostermann | Zendy; Sharon Weissman | Zendy; Amy Hobbie | Zendy; Noor Alshareef | Zendy; Andrew Weinhold | Zendy; Valerie Yelverton | Zendy; Nathan M. Thielman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Who Wants to Switch? Gauging Patient Interest in Novel Antiretroviral Therapies

Author(s) -

Caroline Derrick,

Jan Ostermann,

Sharon Weissman,

Amy Hobbie,

Noor Alshareef,

Andrew Weinhold,

Valerie Yelverton,

Nathan M. Thielman

Publication year - 2018

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofy247

Subject(s) - medicine , dosing , regimen , human immunodeficiency virus (hiv) , cohort , antiretroviral therapy , intensive care medicine , drug holiday , family medicine , viral load

Study participants were asked about their interest in switching to novel drug delivery systems that reduce the dosing frequency of antiretroviral regimens. Across a diverse, treatment-experienced cohort, we describe greatest interest in switching to an oral regimen taken once weekly, followed by injections taken every other month and twice-annual implants.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research